|
|
|
| home > white papers > Achieve full compliance with tamper-verification pharma solutions - UPM Raflatac |
|
|
 WHITE PAPERS |
|
UPM Raflatac
|
|
Achieve full compliance with tamper-verification pharma solutions
|
|
UPM Raflatac has developed a range of pharmaceutical labelling products to support compliance with the Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. Few solutions offer the same ease of adoption for meeting the February 2019 deadline.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
FlyPharma Conference Europe 2022 Shares the Latest Supply Chain Challenges and Advice for Better Industry Collaboration
On 20-21 September 2022, the FlyPharma Conference Europe made a
welcome return as a live, in-person event. The conference was warmly
received by its delegates and declared a resounding success, with some
familiar faces from previous events and many new ones in attendance
across the two days.
More info >> |
|
 |
White Papers |
 |
|
Blockbuster Drugs Need Blockbuster Components
West Pharmaceutical Services, Inc.
Many of the world’s blockbuster drugs are now delivered via a prefilled syringe system or auto-injector. To ensure patient safety, pharmaceutical manufacturers need high-quality components that feature reduced particulates and ensure consistency of delivery while fitting the changing needs of higher-volume delivery systems.
More info >> |
|
|
|
